ArticleJCI insight2024

CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon.

Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.